
The pharmaceutical industry’s growth prospects look promising, given an aging population, an increase in the prevalence of chronic diseases, and a greater focus on personalized medical treatment. The development of newer drugs and therapies will further fuel industry expansion.
Given the industry’s solid growth prospects, investors could consider buying fundamentally strong pharma stocks Merck & Co., Inc. (MRK), AbbVie Inc. (ABBV), and GSK plc (GSK).